The GLP-1 Receptor Agonist Market comprises medications that mimic the effects of endogenous glucagon-like peptide-1 (GLP-1). GLP-1 receptor agonists are used for the management of type 2 diabetes by stimulating insulin secretion, suppressing glucagon secretion, slowing gastric emptying and increasing satiety. They serve as a viable alternative to insulin and sulphonylureas for individuals with type 2 diabetes. The increasing prevalence of type 2 diabetes worldwide driven by obesity, ... Read more
